title: [Inhibitory effects of macrolides on exaggerated production of vascular endothelial growth factor (VEGF) caused by co-stimulation by hypoxia and TNF-alpha].
authors.forename: Akishi
authors.initials: A
authors.lastname: Matsune
authors.forename: Do
authors.initials: D
authors.lastname: Sun
authors.forename: Junichiro
authors.initials: J
authors.lastname: Obori
authors.forename: Masato
authors.initials: M
authors.lastname: Ushikai
authors.forename: Yuichi
authors.initials: Y
authors.lastname: Kurono
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D015687:Cell Hypoxia / Q000502:physiology*; D002478:Cells, Cultured; D017291:Clarithromycin / Q000494:pharmacology*; D003907:Dexamethasone / Q000494:pharmacology; D006801:Humans; D015575:Roxithromycin / Q000494:pharmacology*; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*; D042461:Vascular Endothelial Growth Factor A / Q000096:biosynthesis*
chemical_list: D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D014409:Tumor Necrosis Factor-alpha; D042461:Vascular Endothelial Growth Factor A; D015575:Roxithromycin; D003907:Dexamethasone; D017291:Clarithromycin